114 related articles for article (PubMed ID: 11911268)
1. Modulation of CD99/MIC2 expression of human AHTO-7 osteoblasts by carcinoma cell line-conditioned media.
Hamilton D; Mallinger R; Millesi H; Engel A; Baumgartner G; Raderer M
Anticancer Res; 2001; 21(6A):3909-13. PubMed ID: 11911268
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.
Ulsperger E; Hamilton G; Raderer M; Baumgartner G; Hejna M; Hoffmann O; Mallinger R
Int J Oncol; 1999 Nov; 15(5):955-9. PubMed ID: 10536179
[TBL] [Abstract][Full Text] [Related]
3. Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factors.
Ulsperger E; Hamilton G; Olszewski U; Baumgartner G; Engel A; Mallinger R
Oncol Rep; 2003; 10(5):1529-34. PubMed ID: 12883736
[TBL] [Abstract][Full Text] [Related]
4. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
[TBL] [Abstract][Full Text] [Related]
5. Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.
Oranger A; Brunetti G; Carbone C; Colaianni G; Mongelli T; Gigante I; Tamma R; Mori G; Di Benedetto A; Sciandra M; Ventura S; Scotlandi K; Colucci S; Grano M
J Immunol Res; 2015; 2015():156787. PubMed ID: 26000312
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of osteoblastic cell differentiation by conditioned medium derived from the human prostatic cancer cell line PC-3 in vitro.
Kido J; Yamauchi N; Ohishi K; Kataoka M; Nishikawa S; Nakamura T; Kadono H; Ikedo D; Ueno A; Nonomura N; Okuyama A; Nagata T
J Cell Biochem; 1997 Nov; 67(2):248-56. PubMed ID: 9328830
[TBL] [Abstract][Full Text] [Related]
9. Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer.
Shen J; Zhau HE; Hursting SD; Chung LW
Mol Carcinog; 1998 Sep; 23(1):13-9. PubMed ID: 9766433
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts.
Pinski J; Parikh A; Bova GS; Isaacs JT
Cancer Res; 2001 Sep; 61(17):6372-6. PubMed ID: 11522628
[TBL] [Abstract][Full Text] [Related]
11. CD99/MIC2 Constitutes a Differentiation Antigen of a Human Osteoblast Cell Line.
Hamilton G; Olszewski-Hamilton U
World J Oncol; 2011 Dec; 2(6):298-304. PubMed ID: 29147265
[TBL] [Abstract][Full Text] [Related]
12. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET
Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer cells induce osteoblastic differentiation via semaphorin 3A.
Liu F; Shen W; Qiu H; Hu X; Zhang C; Chu T
Prostate; 2015 Mar; 75(4):370-80. PubMed ID: 25421946
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.
Gao J; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Prostate; 2007 Mar; 67(4):348-60. PubMed ID: 17221837
[TBL] [Abstract][Full Text] [Related]
16. IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells.
Bhattacharyya RS; Stern PH
J Cell Biochem; 2003 Dec; 90(5):925-37. PubMed ID: 14624452
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.
Pagel CN; Kularathna PK; Sanaei R; Young ND; Hooper JD; Mackie EJ
Prostate; 2022 May; 82(6):723-739. PubMed ID: 35167724
[TBL] [Abstract][Full Text] [Related]
18. New Roles of Osteocytes in Proliferation, Migration and Invasion of Breast and Prostate Cancer Cells.
Cui YX; Evans BA; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1193-201. PubMed ID: 26977015
[TBL] [Abstract][Full Text] [Related]
19. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
20. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
Heino TJ; Hentunen TA; Väänänen HK
Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
